Journal of Clinical Endocrinology & Metabolism, Vol 55, 219-227, Copyright © 1982 by Endocrine Society

ARTICLES

Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity

AF Stewart, A Vignery, A Silverglate, ND Ravin, V LiVolsi, AE Broadus and R Baron

Humoral hypercalcemia of malignancy (HHM) results from elaboration by tumors of a circulating bone-resorbing factor(s). THe specific mechanism responsible for this bone resorption is poorly understood, and no comprehensive study employing quantitative histomorphometric analyses of bone biopsies obtained from living patients with HHM has been reported. We describe bone histology and quantitative bone histomorphometry in bone biopsies obtained from seven patients defined biochemically (elevated nephrogenous cAMP excretion) and histologically (no tumor in biopsy sample) as having HHM. These biopsies are compared to biopsies from nine patients with primary hyperparathyroidism (HPT). Compared to patients with HPT, those with HHM displayed (mean +/- SD) greater osteoclastic activity (osteoclast surface, 8.6 +/- 6.1% vs. 2.7 +/- 1.5%; P less than 0.001) and more frequent empty lacunae (9.2 +/- 4.0% vs. 5.8 +/- 3.0%; P less than 0.01), but markedly reduced osteoblastic surface (2.5 +/- 3.1% vs. 13.8 +/- 7.0%; P less than 0.001), osteoid surface (12.9 +/- 11.9% vs. 42.0 +/- 15.0%; P less than 0.001), and osteoid volume (0.3 +/- 0.3% vs. 1.3 +/- 1.0%; P less than 0.01). These findings directly confirm the presence of humorally mediated bone resorption and indicate a striking uncoupling of osteoclast and osteoblast activities in bone from patients with HHM. These findings are in sharp contrast to those in HPT patients, where osteoclast and osteoblast activities are tightly coupled, and net skeletal calcium loss is minimal. This uncoupling provides a mechanism for the marked skeletal calcium losses observed in patients with HHM.

This article has been cited by other articles:

				R. E. Miller, M. Roudier, J. Jones, A. Armstrong, J. Canon, and W. C. Dougall RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis Mol. Cancer Ther., July 1, 2008; 7(7): 2160 - 2169. [Abstract] [Full Text] [PDF]

				P. A. Phadke, R. R. Mercer, J. F. Harms, Y. Jia, A. R. Frost, J. L. Jewell, K. M. Bussard, S. Nelson, C. Moore, J. C. Kappes, et al. Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone Clin. Cancer Res., March 1, 2006; 12(5): 1431 - 1440. [Abstract] [Full Text] [PDF]

				H. Vacher-Coponat, A. Opris, A. Denizot, B. Dussol, and Y. Berland Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2832 - 2835. [Full Text] [PDF]

				G A Clines and T A Guise Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583. [Abstract] [Full Text] [PDF]

				A. Schneider, L. M. Kalikin, A. C. Mattos, E. T. Keller, M. J. Allen, K. J. Pienta, and L. K. McCauley Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton Endocrinology, April 1, 2005; 146(4): 1727 - 1736. [Abstract] [Full Text] [PDF]

				A. F. Stewart Hypercalcemia Associated with Cancer N. Engl. J. Med., January 27, 2005; 352(4): 373 - 379. [Full Text] [PDF]

				B. L. Eckhardt, B. S. Parker, R. K. van Laar, C. M. Restall, A. L. Natoli, M. D. Tavaria, K. L. Stanley, E. K. Sloan, J. M. Moseley, and R. L. Anderson Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix Mol. Cancer Res., January 1, 2005; 3(1): 1 - 13. [Abstract] [Full Text] [PDF]

				A. Bisello, M. J. Horwitz, and A. F. Stewart Parathyroid Hormone-Related Protein: An Essential Physiological Regulator of Adult Bone Mass Endocrinology, August 1, 2004; 145(8): 3551 - 3553. [Full Text] [PDF]

				M. J. Horwitz, M. B. Tedesco, S. M. Sereika, B. W. Hollis, A. Garcia-Ocana, and A. F. Stewart Direct Comparison of Sustained Infusion of Human Parathyroid Hormone-Related Protein-(1-36) [hPTHrP-(1-36)] Versus hPTH-(1-34) on Serum Calcium, Plasma 1,25-Dihydroxyvitamin D Concentrations, and Fractional Calcium Excretion in Healthy Human Volunteers J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1603 - 1609. [Abstract] [Full Text] [PDF]

				M. J. Horwitz, M. B. Tedesco, C. Gundberg, A. Garcia-Ocana, and A. F. Stewart Short-Term, High-Dose Parathyroid Hormone-Related Protein as a Skeletal Anabolic Agent for the Treatment of Postmenopausal Osteoporosis J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 569 - 575. [Abstract] [Full Text] [PDF]

				A. Garcia-Ocana, K. K. Takane, M. A. Syed, W. M. Philbrick, R. C. Vasavada, and A. F. Stewart Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia J. Biol. Chem., January 14, 2000; 275(2): 1226 - 1232. [Abstract] [Full Text] [PDF]

				H. Plotkin, C. Gundberg, M. Mitnick, and A. F. Stewart Dissociation of Bone Formation from Resorption during 2-Week Treatment with Human Parathyroid Hormone-Related Peptide-(1-36) in Humans: Potential as an Anabolic Therapy for Osteoporosis J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2786 - 2791. [Abstract] [Full Text]

				A. Takaori-Kondo, K. Imada, I. Yamamoto, A. Kunitomi, Y. Numata, H. Sawada, and T. Uchiyama Parathyroid Hormone-Related Protein-Induced Hypercalcemia in SCID Mice Engrafted With Adult T-Cell Leukemia Cells Blood, June 15, 1998; 91(12): 4747 - 4751. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				J. G. Henry, M. Mitnick, P. R. Dann, and A. F. Stewart Parathyroid Hormone-Related Protein-(1-36) Is Biologically Active When Administered Subcutaneously to Humans J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 900 - 906. [Abstract] [Full Text] [PDF]

				R. C. Vasavada, C. Cavaliere, A. J. D'Ercole, P. Dann, W. J. Burtis, A. L. Madlener, K. Zawalich, W. Zawalich, W. Philbrick, and A. F. Stewart Overexpression of Parathyroid Hormone-related Protein in the Pancreatic Islets of Transgenic Mice Causes Islet Hyperplasia, Hyperinsulinemia, and Hypoglycemia J. Biol. Chem., January 12, 1996; 271(2): 1200 - 1208. [Abstract] [Full Text] [PDF]

				J. Merendino Jr, K. Insogna, L. Milstone, A. Broadus, and A. Stewart A parathyroid hormone-like protein from cultured human keratinocytes Science, January 24, 1986; 231(4736): 388 - 390. [Abstract] [PDF]

				D. Miao, X.-K. Tong, G. K. Chan, D. Panda, P. S. McPherson, and D. Goltzman Parathyroid Hormone-related Peptide Stimulates Osteogenic Cell Proliferation through Protein Kinase C Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway J. Biol. Chem., August 17, 2001; 276(34): 32204 - 32213. [Abstract] [Full Text] [PDF]